Anti-EBV antibody titers in Italian patients with nasopharyngeal carcinoma
Affiliations
- PMID: 2842481
Item in Clipboard
Anti-EBV antibody titers in Italian patients with nasopharyngeal carcinoma
J Exp Pathol.
1987 Summer.
Abstract
In September 1983 we started the serological examination of all patients with a nasopharyngeal carcinoma (NPC) to evaluate whether the association between NPC and EBV is present even in Italy. At present we have data from 60 patients. This paper confirms the presence of the antibodies to EBV in 75% of Italian NPC patients with a significant difference in respect to control groups. Thus, we consider this serological test as a good marker for NPC and especially useful in cases presenting a difficult diagnosis. In our brief experience it seems that the same test is not so useful to indicate healing, stationariness, or the initial relapse of the tumor.
Similar articles
-
Nasopharyngeal carcinoma: the diagnostic value of the antibody-dependent, cellular cytotoxicity test and of EBV serology.J Exp Pathol. 1987 Summer;3(4):471-7. J Exp Pathol. 1987. PMID: 2842480
-
Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.Cancer. 2004 Mar 15;100(6):1162-70. doi: 10.1002/cncr.20099. Cancer. 2004. PMID: 15022282
-
The reliability of IgA antibody to Epstein-Barr virus (EBV) capsid antigen as a test for the diagnosis of nasopharyngeal carcinoma (NPC).Cancer Detect Prev. 1981;4(1-4):307-12. Cancer Detect Prev. 1981. PMID: 6299561
-
[Value of anti-Epstein-Barr antibody detection in the diagnosis and management of undifferentiated carcinoma of the nasopharynx].Bull Cancer Radiother. 1996;83(1):3-7. Bull Cancer Radiother. 1996. PMID: 8679277 Review. French.
-
Nasopharyngeal carcinoma and Epstein-Barr virus--associated serologic markers.Ear Nose Throat J. 1990 Apr;69(4):261-7. Ear Nose Throat J. 1990. PMID: 2161732 Review.